BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 24590433)

  • 1. External validation of online predictive models for prediction of cancer-specific mortality and all-cause mortality in patients with urothelial carcinoma of the urinary bladder.
    Moon KC; Kim M; Kwak C; Kim HH; Ku JH
    Ann Surg Oncol; 2014 Sep; 21(9):3132-41. PubMed ID: 24590433
    [TBL] [Abstract][Full Text] [Related]  

  • 2. External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder.
    Nuhn P; May M; Sun M; Fritsche HM; Brookman-May S; Buchner A; Bolenz C; Moritz R; Herrmann E; Burger M; Tilki D; Trojan L; Perrotte P; Haferkamp A; Hohenfellner M; Wieland WF; Müller SC; Karakiewicz PI; Bastian PJ
    Eur Urol; 2012 Jan; 61(1):58-64. PubMed ID: 21840642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. External validation of preoperative and postoperative nomograms for prediction of cancer-specific survival, overall survival and recurrence after robot-assisted radical cystectomy for urothelial carcinoma of the bladder.
    Al-Daghmin A; English S; Kauffman EC; Din R; Khan A; Syed JR; Sztorc J; Mehedint D; Sharif M; Shi Y; Wilding G; Guru KA
    BJU Int; 2014 Aug; 114(2):253-60. PubMed ID: 24119175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Cancer of the Bladder Risk Assessment (COBRA) score for predicting cancer-specific survival after radical cystectomy for urothelial carcinoma of the bladder: External validation in a cohort of Korean patients.
    Kim HS; Kwak C; Kim HH; Ku JH
    Urol Oncol; 2019 Jul; 37(7):470-477. PubMed ID: 30935845
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
    Karakiewicz PI; Shariat SF; Palapattu GS; Gilad AE; Lotan Y; Rogers CG; Vazina A; Gupta A; Bastian PJ; Perrotte P; Sagalowsky AI; Schoenberg M; Lerner SP
    J Urol; 2006 Oct; 176(4 Pt 1):1354-61; discussion 1361-2. PubMed ID: 16952631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort.
    Aziz A; May M; Burger M; Palisaar RJ; Trinh QD; Fritsche HM; Rink M; Chun F; Martini T; Bolenz C; Mayr R; Pycha A; Nuhn P; Stief C; Novotny V; Wirth M; Seitz C; Noldus J; Gilfrich C; Shariat SF; Brookman-May S; Bastian PJ; Denzinger S; Gierth M; Roghmann F;
    Eur Urol; 2014 Jul; 66(1):156-63. PubMed ID: 24388438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nomograms provide improved accuracy for predicting survival after radical cystectomy.
    Shariat SF; Karakiewicz PI; Palapattu GS; Amiel GE; Lotan Y; Rogers CG; Vazina A; Bastian PJ; Gupta A; Sagalowsky AI; Schoenberg M; Lerner SP
    Clin Cancer Res; 2006 Nov; 12(22):6663-76. PubMed ID: 17121885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative nomogram for invasive bladder cancer: does it really work? A multicenter cohort study.
    Bassi PF; Bongiovanni L; Racioppi M; Volpe A; D'Agostino D; Gardi M; ;
    Urol Oncol; 2011; 29(6):698-702. PubMed ID: 19959381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting individual outcomes after radical cystectomy: an external validation of current nomograms.
    Zaak D; Burger M; Otto W; Bastian PJ; Denzinger S; Stief CG; Buchner H; Hartmann A; Wieland WF; Shariat SF; Fritsche HM
    BJU Int; 2010 Aug; 106(3):342-8. PubMed ID: 20002664
    [TBL] [Abstract][Full Text] [Related]  

  • 10. External Validation of Bladder Cancer Predictive Nomograms for Recurrence, Cancer-Free Survival and Overall Survival following Radical Cystectomy.
    Brooks M; Godoy G; Sun M; Shariat SF; Amiel GE; Lerner SP
    J Urol; 2016 Feb; 195(2):283-9. PubMed ID: 26343350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nomogram for predicting survival in patients with unresectable and/or metastatic urothelial cancer who are treated with cisplatin-based chemotherapy.
    Galsky MD; Moshier E; Krege S; Lin CC; Hahn N; Ecke T; Sonpavde G; Godbold J; Oh WK; Bamias A
    Cancer; 2013 Aug; 119(16):3012-9. PubMed ID: 23720216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of the Memorial Sloan Kettering Cancer Center nomogram in the prognosis of patients treated with radical cystectomy for invasive bladder cancer.
    Molina Escudero R; Herranz Amo F; Monzo Gardiner J; Paez Borda A; Hernandez Fernandez C
    Arch Esp Urol; 2013 Nov; 66(9):859-64. PubMed ID: 24231296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and validation of a prognostic nomogram for predicting cancer-specific survival after radical cystectomy in patients with bladder cancer:A population-based study.
    Yang Z; Bai Y; Liu M; Hu X; Han P
    Cancer Med; 2020 Dec; 9(24):9303-9314. PubMed ID: 33063464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External validation of an online nomogram in patients undergoing radical nephroureterectomy for upper urinary tract urothelial carcinoma.
    Ku JH; Moon KC; Jung JH; Jeong SH; Kwak C; Kim HH
    Br J Cancer; 2013 Sep; 109(5):1130-6. PubMed ID: 23949152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The SPARC score: a multifactorial outcome prediction model for patients undergoing radical cystectomy for bladder cancer.
    Eisenberg MS; Boorjian SA; Cheville JC; Thompson RH; Thapa P; Kaushik D; Frank I
    J Urol; 2013 Dec; 190(6):2005-10. PubMed ID: 23770147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nomogram predicted survival of patients with adenocarcinoma of esophagogastric junction.
    Zhou Z; Zhang H; Xu Z; Li W; Dang C; Song Y
    World J Surg Oncol; 2015 Jun; 13():197. PubMed ID: 26055624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative performance of comorbidity indices for estimating perioperative and 5-year all cause mortality following radical cystectomy for bladder cancer.
    Boorjian SA; Kim SP; Tollefson MK; Carrasco A; Cheville JC; Thompson RH; Thapa P; Frank I
    J Urol; 2013 Jul; 190(1):55-60. PubMed ID: 23313198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Accurate preoperative prediction of non-organ-confined bladder urothelial carcinoma at cystectomy.
    Green DA; Rink M; Hansen J; Cha EK; Robinson B; Tian Z; Chun FK; Tagawa S; Karakiewicz PI; Fisch M; Scherr DS; Shariat SF
    BJU Int; 2013 Mar; 111(3):404-11. PubMed ID: 22805163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomograms predicting response to therapy and outcomes after bladder-preserving trimodality therapy for muscle-invasive bladder cancer.
    Coen JJ; Paly JJ; Niemierko A; Kaufman DS; Heney NM; Spiegel DY; Efstathiou JA; Zietman AL; Shipley WU
    Int J Radiat Oncol Biol Phys; 2013 Jun; 86(2):311-6. PubMed ID: 23474117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative prognostic nomogram (probability table) for renal cell carcinoma based on TNM classification.
    Kanao K; Mizuno R; Kikuchi E; Miyajima A; Nakagawa K; Ohigashi T; Nakashima J; Oya M
    J Urol; 2009 Feb; 181(2):480-5; discussion 485. PubMed ID: 19100568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.